The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
https://www.asiaone.com/business/synairgen-announces-data-home-cohort-sg016-phase-ii-trial-inhaled-interferon-beta-covid-19 Theres definitely opposing views on the data, like a lot of us on here i'm down but not out!
https://www.frontiersin.org/articles/10.3389/fimmu.2021.651254/full
https://www.sortiraparis.com/news/in-paris/articles/212134-coronavirus-in-the-world-as-of-datadatestodayfrlatest-latest-case-and-death-toll/lang/en
Off topic but shows the virus isnt going away just yet
https://www.gabionline.net/Biosimilars/Research/Efficacy-and-safety-of-interferon-beta-1a-ReciGen-in-COVID-19
sng not mentioned but compares to our study last paragraph
https://hms.harvard.edu/news/one-year-therapeutics
sng not mentioned but worth a read.
https://link.springer.com/article/10.1007/s00210-021-02061-x#Sec15
https://www.voanews.com/covid-19-pandemic/us-researchers-say-covid-19-antiviral-shows-promise